HuGE Literature Finder
Records
1
-
5
Akt1 genetic variants confer increased susceptibility to thyroid cancer. Endocrine connections 2020 Oct . Crezee Thomas, Petrulea Mirela, Piciu Doina, Jaeger Martin, Smit Jan Wa, Plantinga Theo S, Georgescu Carmen E, Netea-Maier Roma |
Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History. OncoTargets and therapy 2020 13 8795-8802. He Wenwu, Leng Xuefeng, Yang Yanyu, Peng Lin, Shao Yang, Li Xue, Han Yongt |
Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2013 Mar 189 (3): 202-14. Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras K T, Fountzilas |
Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk. Journal of the National Cancer Institute 2013 Feb . Shu X, Lin J, Wood CG, Tannir NM, Wu X |
Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece. Endocrine pathology 2010 Jun 21 (2): 90-100. Sozopoulos Elias, Litsiou Helen, Voutsinas Gerassimos, Mitsiades Nikolaos, Anagnostakis Nikolaos, Tseva Thomais, Patsouris Efstratios, Tseleni-Balafouta Sof |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: